Archive for the ‘PROSTATE RESEARCH’ Category

URO TODAY: New research findings suggest that PSA alone, in the under 40 age group, is not effective for detecting prostate cancer. READ MORE>

Read Full Post »

NEW PROSTATE CANCER INFOLINK: The idea that B2M expression or activity might have some significant impact on the androgen signaling axis in patients with prostate cancer is interesting, and has potential future implications for the prognosis and even the treatment of prostate cancer (assuming that these new findings can be confirmed by others). READ MORE> and HERE>

Read Full Post »

URO TODAY: A non-invasive rectal probe (if that’s not an oxymoron) used to detect zinc levels in the proximity of the prostate gland may be a new and accurate way to detect prostate cancer and its seriousness, researchers say. READ MORE>

Zinc depletion in the prostate peripheral zone is the basis for a novel, non-invasive prostate cancer detection, localization, volume evaluation and grading method.

Read Full Post »

NEW PROSTATE CANCER INFOLINK: Guidelines from several organizations now suggest that men should be thoroughly informed about the pros and cons of PSA testing before starting to receive such tests (regardless of frequency) as a means to assess possible risk for prostate cancer. READ MORE>

Read Full Post »

NEW PROSTATE CANCER INFOLINK: A recent article in Cancer seems to further support Stamey’s contention (published in 2004) that — at least in the USA — the PSA test has a great deal less value as a screening test for prostate cancer today than it had when it was initially introduced in the 1980s and 1990s. READ MORE>

Read Full Post »

PROSTABLOG NZ: Prostate cancer is the most commonly diagnosed cancer in NZ, says Minister of Health Tony Ryall, but the biggest killer is lung cancer. READ MORE>

Read Full Post »

NEW PROSTATE CANCER INFOLINK: A detailed analysis of the findings of a Swedish study into the effectiveness of prostate cancer screening using PSA tests is provided here by Mike Scott: READ MORE>

The data from the Göteborg study may still not provide a convincing rationale for mass, population-based screening based on use of the PSA test, but it certainly does set the standard for what must be expected from any new test that may come along and show promise as a true screening test for prostate cancer in the future.

Earlier stories

Reuters and other news agencies gave widespread coverage to the Swedish study over recent days.

REUTERS: An extensive study of 20,000 men into the merits of screening men between the ages of 50 and 65 for prostate cancer has found it can cut death rates from the disease by as much as half, report Swedish scientists. READ MORE> and HERE> and HERE> and HERE> and HERE>

Over 14 years of follow-up, prostate cancer death rates were cut almost by half in the (PSA) screening group compared with the non-screening group, as men were diagnosed and treated in time to stop the cancer from killing them.

Jonas Hugosson, who led the study, said the results showed that PSA screening of all men this age group “can result in a relevant reduction in cancer mortality.”

But the findings don’t necessarily mean nationwide prostate screening programs should introduced, experts said, since they run the risk of significant overdiagnosis of tumors in men who would not have suffered any harm from their cancer.

Read Full Post »

URO TODAY: Early baldness may be a sign that a man won’t get prostate cancer, a new study suggests. READ MORE>

We did not find consistent positive associations between androgenic alopecia at different ages and prostate cancer.

Surprisingly, if anything, baldness at early age is inversely related to prostate cancer in this study. Androgenic alopecia is not useful as an indicator of men at high risk of prostate cancer.

Read Full Post »

URO TODAY: Robot-assisted surgery for prostate cancer is now the preferred method in the US, where a study says its benefits outweigh other methods. READ MORE>

While cost remains a valid criticism to the robotic technique, some of the additional expenditure is offset by improved convalescence, fewer medical complications, and decreased morbidity.

Data with follow up approaching 10 years demonstrates equal if not superior outcomes with respect to continence, sexual and oncological factors.

Read Full Post »

URO TODAY: Better follow-up care is needed for men recovering from prostate cancer treatment, a US study finds. READ MORE>

Nurses, as well as general practitioners, must play a more active role in follow-up to ensure that the men and their spouses receive better help and support.

Read Full Post »

« Newer Posts - Older Posts »